Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
28,123,106
-
Share change
-
+354,475
-
Total reported value
-
$1,305,218,971
-
Put/Call ratio
-
3659%
-
Price per share
-
$46.29
-
Number of holders
-
165
-
Value change
-
-$1,109,238
-
Number of buys
-
66
-
Number of sells
-
114
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2015
As of 31 Dec 2015,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,123,106 shares.
The largest 10 holders included
Fisher Asset Management, LLC, AQR CAPITAL MANAGEMENT LLC, COMMONWEALTH BANK OF AUSTRALIA, VANGUARD GROUP INC, VONTOBEL ASSET MANAGEMENT INC, BlackRock Group LTD, DIMENSIONAL FUND ADVISORS LP, CREDIT SUISSE AG/, ACADIAN ASSET MANAGEMENT LLC, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.